Review ArticleReview
Open Access

The non-syndromic clinical spectrums of mtDNA 3243A>G mutation

Xiya Shen and Ailian Du
Neurosciences Journal April 2021, 26 (2) 128-133; DOI: https://doi.org/10.17712/nsj.2021.2.20200145

References

  1. 1.↵
    1. Finsterer J,
    2. Zarrouk-Mahjoub S.
    Assessment of the phenotype genotype variability and correlation in m.3243A > G mutation carriers requires prospective studies. Mol Genet Metab Rep 2016; 8: 33.
    OpenUrl
  2. 2.↵
    1. Gorman GS,
    2. Schaefer AM,
    3. Ng Y,
    4. Gomez N,
    5. Blakely EL,
    6. Alston CL, et al.
    Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015; 77: 753-759.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Ng YS,
    2. Grady JP,
    3. Lax NZ,
    4. Bourke JP,
    5. Alston CL,
    6. Hardy SA, et al.
    Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults. Eur Heart J 2016; 37: 2552-2559.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Elliott HR,
    2. Samuels DC,
    3. Eden JA,
    4. Relton CL,
    5. Chinnery PF.
    Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008; 83: 254-260.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. de Laat P,
    2. Fleuren LH,
    3. Bekker MN,
    4. Smeitink JA,
    5. Janssen MC.
    Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome. Mitochondrion 2015; 25: 98-103.
    OpenUrlPubMed
  6. 6.↵
    1. Iizuka T,
    2. Sakai F,
    3. Suzuki N,
    4. Hata T,
    5. Tsukahara S,
    6. Fukuda M, et al.
    Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002; 59: 816-824.
    OpenUrlCrossRef
  7. 7.↵
    1. Chin J,
    2. Marotta R,
    3. Chiotis M,
    4. Allan EH,
    5. Collins SJ.
    Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective. Mitochondrion 2014; 17: 34-41.
    OpenUrlPubMed
  8. 8.↵
    1. Imai-Okazaki A,
    2. Kishita Y,
    3. Kohda M,
    4. Mizuno Y,
    5. Fushimi T,
    6. Matsunaga A, et al.
    Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background. Int J Cardiol 2019; 279: 115-121.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Feeney CL,
    2. Lim AZ,
    3. Fagan E,
    4. Blain A,
    5. Bright A,
    6. Maddison J, et al.
    A case-comparison study of pregnant women with mitochondrial disease - what to expect? Bjog 2019; 126: 1380-1389.
    OpenUrlPubMed
  10. 10.↵
    1. Miyaoka H,
    2. Suzuki Y,
    3. Taniyama M,
    4. Miyaoka Y,
    5. Shishikura K,
    6. Kamijima K, et al.
    Mental disorders in diabetic patients with mitochondrial transfer RNA(Leu) (UUR) mutation at position 3243. Biol Psychiatry 1997; 42: 524-526.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Verhaak C,
    2. de Laat P,
    3. Koene S,
    4. Tibosch M,
    5. Rodenburg R,
    6. de Groot I, et al.
    Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation. Orphanet J Rare Dis 2016; 11: 25.
    OpenUrlPubMed
  12. 12.↵
    1. Pickett SJ,
    2. Grady JP,
    3. Ng YS,
    4. Gorman GS,
    5. Schaefer AM,
    6. Wilson IJ, et al.
    Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors. Ann Clin Transl Neurol 2018; 5: 333-345.
    OpenUrl
  13. 13.↵
    1. Sullivan PF,
    2. Neale MC,
    3. Kendler KS.
    Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157: 1552-1562.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Dodick DW. Migraine
    . The Lancet 2018; 391: 1315-30.
    OpenUrl
  15. 15.↵
    1. Kraya T,
    2. Deschauer M,
    3. Joshi PR,
    4. Zierz S,
    5. Gaul C.
    Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study. Headache 2018; 58: 45-52.
    OpenUrl
  16. 16.↵
    1. Guo S,
    2. Esserlind AL,
    3. Andersson Z,
    4. Frederiksen AL,
    5. Olesen J,
    6. Vissing J, et al.
    Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA. Eur J Neurol 2016; 23: 175-181.
    OpenUrl
  17. 17.↵
    1. Tiehuis LH,
    2. Koene S,
    3. Saris CGJ,
    4. Janssen MCH.
    Mitochondrial migraine; a prevalence, impact and treatment efficacy cohort study. Mitochondrion 2020; 53: 128-132.
    OpenUrl
  18. 18.↵
    1. van den Ameele J,
    2. Fuge J,
    3. Pitceathly RDS,
    4. Berry S,
    5. McIntyre Z,
    6. Hanna MG, et al.
    Chronic pain is common in mitochondrial disease. Neuromuscul Disord 2020; 30: 413-419.
    OpenUrl
  19. 19.↵
    1. Smeitink J,
    2. Koene S,
    3. Beyrath J,
    4. Saris C,
    5. Turnbull D,
    6. Janssen M.
    Mitochondrial Migraine: Disentangling the angiopathy paradigm in m.3243A>G patients. JIMD Rep 2019; 46: 52-62.
    OpenUrl
  20. 20.↵
    1. Kaufmann P,
    2. Pascual JM,
    3. Anziska Y,
    4. Gooch CL,
    5. Engelstad K,
    6. Jhung S, et al.
    Nerve conduction abnormalities in patients with MELAS and the A3243G mutation. Arch Neurol 2006; 63: 746-748.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Tsujikawa K,
    2. Senda J,
    3. Yasui K,
    4. Hasegawa Y,
    5. Hoshiyama M,
    6. Katsuno M, et al.
    Distinctive distribution of brain volume reductions in MELAS and mitochondrial DNA A3243G mutation carriers: A voxel-based morphometric study. Mitochondrion 2016; 30: 229-235.
    OpenUrl
  22. 22.↵
    1. Yokoyama T,
    2. Hasegawa K,
    3. Obama R,
    4. Ishihara T,
    5. Yagishita S.
    MELAS with diffuse degeneration of the cerebral white matter: report of an autopsy case. Neuropathology 2010; 30: 56-60.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Ma Y,
    2. Fang F,
    3. Cao Y,
    4. Yang Y,
    5. Zou L,
    6. Zhang Y, et al.
    Clinical features of mitochondrial DNA m.3243A>G mutation in 47 Chinese families. J Neurol Sci 2010; 291: 17-21.
    OpenUrlPubMed
  24. 24.↵
    1. Zhou Y,
    2. Yi J,
    3. Liu L,
    4. Wang X,
    5. Dong L,
    6. Du A.
    Acute mitochondrial myopathy with respiratory insufficiency and motor axonal polyneuropathy. Int J Neurosci 2018; 128: 231-236.
    OpenUrl
  25. 25.↵
    1. Pan X,
    2. Wang L,
    3. Fei G,
    4. Dong J,
    5. Zhong C,
    6. Lu J, et al.
    Acute Respiratory Failure Is the Initial Manifestation in the Adult-Onset A3243G tRNALeu mtDNA Mutation: A Case Report and the Literature Review. Front Neurol 2019; 10: 780.
    OpenUrl
  26. 26.↵
    1. Al-Gadi IS,
    2. Haas RH,
    3. Falk MJ,
    4. Goldstein A,
    5. McCormack SE.
    Endocrine Disorders in Primary Mitochondrial Disease. J Endocr Soc 2018; 2: 361-373.
    OpenUrl
  27. 27.↵
    1. Naing A,
    2. Kenchaiah M,
    3. Krishnan B,
    4. Mir F,
    5. Charnley A,
    6. Egan C, et al.
    Maternally inherited diabetes and deafness (MIDD): diagnosis and management. J Diabetes Complications 2014; 28: 542-546.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Murphy R,
    2. Turnbull DM,
    3. Walker M,
    4. Hattersley AT.
    Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 2008; 25: 383-99.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Niedermayr K,
    2. Pölzl G,
    3. Scholl-Bürgi S,
    4. Fauth C,
    5. Schweigmann U,
    6. Haberlandt E, et al.
    Mitochondrial DNA mutation “m.3243A>G”-Heterogeneous clinical picture for cardiologists (“m.3243A>G”: A phenotypic chameleon). Congenit Heart Dis 2018; 13: 671-677.
    OpenUrlCrossRef
  30. 30.↵
    1. Malfatti E,
    2. Laforêt P,
    3. Jardel C,
    4. Stojkovic T,
    5. Behin A,
    6. Eymard B, et al.
    High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology 2013; 80: 100-105.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Wahbi K,
    2. Bougouin W,
    3. Béhin A,
    4. Stojkovic T,
    5. Bécane HM,
    6. Jardel C, et al.
    Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases. Eur Heart J 2015; 36: 2886-2893.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Cardenas-Robledo S,
    2. Saber Tehrani A,
    3. Blume G,
    4. Kattah JC. Visual,
    5. Ocular Motor
    , and Cochleo-Vestibular Loss in Patients With Heteroplasmic, Maternally-Inherited Diabetes Mellitus and Deafness (MIDD), 3243 Transfer RNA Mutation. J Neuroophthalmol 2016; 36: 134-140.
    OpenUrl
  33. 33.↵
    1. Yu-Wai-Man P,
    2. Newman NJ.
    Inherited eye-related disorders due to mitochondrial dysfunction. Hum Mol Genet 2017; 26: R12-r20.
    OpenUrl
  34. 34.↵
    1. Dvorakova V,
    2. Kolarova H,
    3. Magner M,
    4. Tesarova M,
    5. Hansikova H,
    6. Zeman J, et al.
    The phenotypic spectrum of fifty Czech m.3243A>G carriers. Mol Genet Metab 2016; 118: 288-295.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Inoue A,
    2. Iwasaki S,
    3. Fujimoto C,
    4. Kinoshita M,
    5. Yamasoba T.
    Progression of Peripheral Vestibular Dysfunctions in Patients With a Mitochondrial A3243G Mutation. Otol Neurotol 2019; 40: 359-364.
    OpenUrl
  36. 36.↵
    1. El-Hattab AW,
    2. Adesina AM,
    3. Jones J,
    4. Scaglia F.
    MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 2015; 116: 4-12.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Zhang Z,
    2. Zhao D,
    3. Liu J,
    4. Zuo Y,
    5. Xiong H,
    6. Lyu H, et al.
    Clinical features of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes: an analysis of 190 cases. Chinese Journal of Neurology 2016; 49: 237-242.
    OpenUrl
  38. 38.↵
    1. Stanghellini V,
    2. Cogliandro RF,
    3. de Giorgio R,
    4. Barbara G,
    5. Salvioli B,
    6. Corinaldesi R.
    Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440-452.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Ng YS,
    2. Feeney C,
    3. Schaefer AM,
    4. Holmes CE,
    5. Hynd P,
    6. Alston CL, et al.
    Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination. Ann Neurol 2016; 80: 686-692.
    OpenUrl
  40. 40.↵
    1. Verny C,
    2. Amati-Bonneau P,
    3. Letournel F,
    4. Person B,
    5. Dib N,
    6. Malinge MC, et al.
    Mitochondrial DNA A3243G mutation involved in familial diabetes, chronic intestinal pseudo-obstruction and recurrent pancreatitis. Diabetes Metab 2008; 34: 620-626.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Say RE,
    2. Whittaker RG,
    3. Turnbull HE,
    4. McFarland R,
    5. Taylor RW,
    6. Turnbull DM.
    Mitochondrial disease in pregnancy: a systematic review. Obstet Med 2011; 4: 90-94.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Kuleva M,
    2. Ben Miled S,
    3. Steffann J,
    4. Bonnefont JP,
    5. Rondeau S,
    6. Ville Y, et al.
    Increased incidence of obstetric complications in women carrying mitochondrial DNA mutations: a retrospective cohort study in a single tertiary centre. Bjog 2019; 126: 1372-1379.
    OpenUrl
  43. 43.↵
    1. Kaufmann P,
    2. Engelstad K,
    3. Wei Y,
    4. Kulikova R,
    5. Oskoui M,
    6. Battista V, et al.
    Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 2009; 66: 85-91.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Chae HW,
    2. Na JH,
    3. Kim HS,
    4. Lee YM.
    Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome. Eur J Endocrinol 2020; 183: 505-512.
    OpenUrl
  45. 45.↵
    1. Xia CY,
    2. Liu Y,
    3. Liu H,
    4. Zhang YC,
    5. Ma YN,
    6. Qi Y.
    Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients with m.3243A>G Mutation in Mitochondrial DNA. Chin Med J (Engl) 2016; 129: 1945-1949.
    OpenUrl
  46. 46.↵
    1. Liu G,
    2. Shen X,
    3. Sun Y,
    4. Lv Q,
    5. Li Y,
    6. Du A.
    Heteroplasmy and phenotype spectrum of the mitochondrial tRNA(Leu (UUR)) gene m.3243A>G mutation in seven Han Chinese families. J Neurol Sci 2020; 408: 116562.
    OpenUrl
  47. 47.↵
    1. de Laat P,
    2. Rodenburg RR,
    3. Roeleveld N,
    4. Koene S,
    5. Smeitink JA,
    6. Janssen MC.
    Six-year prospective follow-up study in 151 carriers of the mitochondrial DNA 3243 A>G variant. J Med Genet 2020.
  48. 48.↵
    1. Sun C,
    2. Lin J,
    3. Cai S,
    4. Zhu W,
    5. Luo S,
    6. Xi J, et al.
    A clinical and natural history research on mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. Chinese Journal of Neurology 2018; 51: 118-123.
    OpenUrl
  49. 49.↵
    1. Kaufmann P,
    2. Engelstad K,
    3. Wei Y,
    4. Kulikova R,
    5. Oskoui M,
    6. Sproule DM, et al.
    Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology 2011; 77: 1965-1971.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Klopstock T,
    2. Jaksch M,
    3. Gasser T.
    Age and cause of death in mitochondrial diseases. Neurology 1999; 53: 855-857.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section